Haemonetics Corporation (HAE)

Days of sales outstanding (DSO)

		Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Receivables turnover		6.71	6.34	6.52	6.23	6.82
DSO	days	54.36	57.59	55.95	58.57	53.49

March 31, 2025 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 6.71
= 54.36

Haemonetics Corporation's days of sales outstanding (DSO) have shown some fluctuations over the past five years. As of March 31, 2021, the company had a DSO of 53.49 days, which increased to 58.57 days by March 31, 2022. However, there was a slight decrease in DSO to 55.95 days by March 31, 2023, followed by a modest increase to 57.59 days by March 31, 2024.

It is worth noting that the data for March 31, 2025 is missing ("- days"), which may indicate a lack of data or an ongoing reporting period. Companies typically aim to lower their DSO metric to improve cash flow efficiency by collecting outstanding receivables more quickly. Therefore, Haemonetics Corporation may need to evaluate its credit policies and collections processes to potentially reduce DSO and enhance liquidity in the future.